Search research articles
Contact Us
Filters
Showing results (971-980 of 992) with videos related to
Page
of 100
Sort By:
Blood
|
March 18, 2014
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal, George Wright, Chao Wang, et al.
Ejhaem
|
September 2, 2022
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy
Marta Rodríguez, Ruth Alonso-Alonso, Ismael Fernández-Miranda, et al.
The Lancet. Haematology
|
September 20, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study
Carlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2022
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice
Catalina Amador, Alyssa Bouska, George Wright, et al.
Leukemia
|
December 24, 2014
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
F Abate, M Todaro, J-A van der Krogt, et al.
Nature Communications
|
September 23, 2021
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
Huan-Chang Liang, Mariantonia Costanza, Nicole Prutsch, et al.
Hemasphere
|
February 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation
Chiara Cosentino, Samir Mouhssine, Antonella Zucchetto, et al.
Nature Communications
|
January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation
Zachary A Hing, Janek S Walker, Ethan C Whipp, et al.
The New England Journal of Medicine
|
September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
Enrico Tiacci, Jae H Park, Luca De Carolis, et al.
Blood
|
January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Page
of 100
Search research articles
Search
Showing results (971-980 of 992) with videos related to
Sort By:
Page
of 100
Blood
|
March 18, 2014
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal, George Wright, Chao Wang, et al.
Ejhaem
|
September 2, 2022
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy
Marta Rodríguez, Ruth Alonso-Alonso, Ismael Fernández-Miranda, et al.
The Lancet. Haematology
|
September 20, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study
Carlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2022
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice
Catalina Amador, Alyssa Bouska, George Wright, et al.
Leukemia
|
December 24, 2014
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
F Abate, M Todaro, J-A van der Krogt, et al.
Nature Communications
|
September 23, 2021
Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma
Huan-Chang Liang, Mariantonia Costanza, Nicole Prutsch, et al.
Hemasphere
|
February 18, 2026
Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation
Chiara Cosentino, Samir Mouhssine, Antonella Zucchetto, et al.
Nature Communications
|
January 7, 2023
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation
Zachary A Hing, Janek S Walker, Ethan C Whipp, et al.
The New England Journal of Medicine
|
September 10, 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
Enrico Tiacci, Jae H Park, Luca De Carolis, et al.
Blood
|
January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies
Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Page
of 100